A randomized phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato® alprazolam for rapid seizure termination

Overview of attention for article published in Epilepsia, December 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 7 X users
patent: 1 patent

reddit: 1 Redditor
video: 1 YouTube creator

Readers on

mendeley: 37 Mendeley

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 154,326 followers.

Epilepsy breakthroughs abound! Cenobamate proves its real-world efficacy in refractory cases. Aerosolized alprazolam emerges as a game-changer for terminating seizures before escalation. ▶️https://t.co/qdLy4bN43S ▶️https://t.co/r4qDooOv6T @SEEpilepsia

[#scientifique] Une étude d'efficacité de phase 2b randomisée chez des patients présentant des épisodes de crise avec un schéma prévisible et utilisant l'alprazolam Staccato ® pour une interruption rapide des crises. 👉https://t.co/zjLn6czxSB #epilepsy …

A randomized Phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato® alprazolam for rapid seizure termination https://t.co/FxT9lS1Aoi

RT @EpilepsiaJourn: A randomized Phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato® #alpr…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.